Applied Therapeutics
Presence
Applied Therapeutics is a company listed under the stock ticker APLT (US).
Executives
View the org chart displaying its 9 main executives
Most searched biographies at Applied Therapeutics
- Shoshana Shendelman, Chief Executive Officer and Chairman of the B...
- Stacy Kanter, Director
- Teena Lerner, Director
Popular executive movements at Applied Therapeutics
- Dale Hooks has joined the company as Chief Commercial Officer (posted on April 16 2024).
- Adam Hansard, Chief Commercial Officer, has left the company (posted on April 16 2024).
- Constantine Chinoporos has joined the company as Chief Operating Officer and Chief Business Officer (posted on January 3 2024).
Click here to view some more movements at Applied Therapeutics
Create your alert
to follow the executive moves at Applied Therapeutics.
Biotechnology
Applied Therapeutics has 2,295 competitors including Lonza (Switzerland), Eurofins (Luxembourg) and Adaptive Phage Therapeutics (United States (USA)).
Popular M&A news in Biotechnology
- Rapport Therapeutics has just announced a $100 Million fundraising (posted on May 20 2024).
- Lycia Therapeutics has just announced a $107 Million fundraising (posted on May 15 2024).
- Attovia Therapeutics has just announced a $150 Million fundraising (posted on May 14 2024).
Popular contacts in Biotechnology
News
Press releases by Applied Therapeutics
- Applied Therapeutics to Present at the 2024 RBC Capital Markets Global Healthcare Conference | Applied Therapeutics
- Applied Therapeutics Reports First Quarter 2024 Financial Results | Applied Therapeutics
- Applied Therapeutics Appoints Dale Hooks as Chief Commercial Officer | Applied Therapeutics
- Applied Therapeutics to Present Results from Phase 3 ARISE-HF Study in Diabetic Cardiomyopathy at ACC 2024 | Applied Therapeutics
- Applied Therapeutics Provides FDA Update on PDUFA Target Action Date for Govorestat for the Treatment of Classic Galactosemia | Applied Therapeutics
- Applied Therapeutics Reports Fourth Quarter and Year-end 2023 Financial Results | Applied Therapeutics
- Applied Therapeutics to Host Diabetic Cardiomyopathy Expert Forum with Key Opinion Leaders on Tuesday, November 7 | Applied Therapeutics
- Applied Therapeutics to Present Baseline Data from Phase 3 ARISE-HF Study Evaluating AT-001 at the 2023 EASD Annual Meeting | Applied Therapeutics
- Applied Therapeutics to Present at the UBS Biopharma Conference 2023 | Applied Therapeutics
- Applied Therapeutics Announces Successful Pre-NDA Meeting with the FDA and Confirms Plans to Submit NDA for Govorestat (AT-007) for Treatment of Classic Galactosemia to FDA in Q4 2023 | Applied Therapeutics
- View more press releases Close
Social media about Applied Therapeutics
- Applied Therapeutics on Wikipedia, Google News & Yahoo Finance
- Applied Therapeutics on LinkedIn, Twitter & YouTube
Get in Touch
Contact by email its executives including Shoshana Shendelman 
Call Applied Therapeutics at +1 917...
